A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumor

by Bauer, S., Berhanu, G., Brandt, U., Gelderblom, H., Grignani, G., Heinrich, M.C, Italiano, A., Pantaleo, M.A, Reichardt, P., Reyners, A.K.L, Schöffski, P., Stark, D., Stefanelli, T., Valverde, C.
Published 2022